Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria
The mechanism of action of omalizumab in urticaria is still not literally known. This study examines the serum values of substance P (SP), calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY), and interleukin-31 (IL-31) in patients using omalizumab. In this study, 30 patients with chronic sp...
Saved in:
Main Authors: | Cagdas Boyvadoglu, Hasan Ulusal, Seyithan Taysı, Goknur Ozaydin-Yavuz, Ibrahim Halil Yavuz, Pınar Korkmaz, Huseyin Serhat Inaloz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2023/8087274 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria
by: Luis Felipe Ensina, et al.
Published: (2025-01-01) -
Efficacy of hydroxychloroquine and omalizumab in a patient with systemic lupus erythematosus, Hashimoto thyroiditis and refractory chronic spontaneous urticaria
by: Öner Özdemir, et al.
Published: (2024-11-01) -
Neuropeptides and Control of Food Intake
by: Paolo de Girolamo, et al.
Published: (2014-01-01) -
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
by: Calum Slapnicar, et al.
Published: (2019-01-01) -
Evaluation of anxiety in children diagnosed with chronic urticaria
by: Ugur Altas, et al.
Published: (2024-04-01)